NCT01441388: A Study Of Crizotinib Plus VEGF Inhibitor Combinations In Patients With Advanced Solid Tumors. |
|
|
| Withdrawn | 1b | 0 | US | Crizotinib plus VEGF inhibitor combinations, Crizotinib plus axitinib, Crizotinib plus sunitinib, Crizotinib plus bevacizumab, Crizotinib plus sorafenib | Pfizer | Carcinoma, Renal Cell, Glioblastoma, Carcinoma, Hepatocellular | 11/13 | 11/13 | | |